maprotiline has been researched along with methoxyhydroxyphenylglycol in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (88.24) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ridges, AP | 1 |
| James, D; Montgomery, DB; Montgomery, SA | 1 |
| Cohen Stuart, MH; de Beurs, P; Høpfner Petersen, HE; Leijnse-Ybema, H; Sanchez, C; Tan, BK; Timmerman, L | 1 |
| Benkelfat, C; Dennis, T; Garreau, M; Loo, H; Poirier, MF; Scatton, B; Sechter, D; Vanelle, JM | 1 |
| Axmann, D; Breyer-Pfaff, U; Gaertner, H; Giedke, H; Rein, W | 1 |
| Benkelfat, C; Dennis, T; Loo, H; Olie, JP; Poirier, MF; Scatton, B; Vanelle, JM | 2 |
| Iida, H; Myojin, T; Taga, C; Tsuji, M; Yamada, N; Yamane, H | 1 |
| Benkelfat, C; Dennis, T; Loo, H; Olie, JP; Poirier, MF; Scatton, B; Susini de Luca, H; Vanelle, JM | 1 |
| Bishop, FM; Goldberg, IJ; Ridges, AP | 1 |
| Breyer-Pfaff, U; Gaertner, HJ; Giedke, H | 1 |
| Cole, JO; Kruger, ER; Maruta, T; Orsulak, PJ; Rohde, WA; Rosenbaum, AH; Schatzberg, AF; Schildkraut, JJ | 1 |
| Breyer-Pfaff, U; Gaertner, HJ; Golfinopoulos, G | 1 |
| Cole, JO; Orsulak, PJ; Rosenbaum, AH; Schatzberg, AF; Schildkraut, JJ | 1 |
| Cole, JO; Grab, EL; Maruta, T; Orsulak, PJ; Rosenbaum, AH; Schatzberg, AF; Schildkraut, JJ | 1 |
| Aricioğlu, F; Canberk, O; Durat, T; Gürvit, G; Ozgüroğlu, M; Sahin, D; Taştaban, Y; Uçok, A; Yazici, O | 1 |
| Hwang, CC; Ko, HC; Lu, RB; Shiah, IS | 1 |
7 trial(s) available for maprotiline and methoxyhydroxyphenylglycol
| Article | Year |
|---|---|
Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
Topics: Adolescent; Adult; Aged; Anthracenes; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Double-Blind Method; Female; Humans; Hydroxyindoleacetic Acid; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales | 1977 |
A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
Topics: Adult; Aged; Anthracenes; Blood Platelets; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dexamethasone; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Propylamines; Serotonin | 1987 |
Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.
Topics: Amitriptyline; Anthracenes; Antidepressive Agents; Arousal; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Prognosis; Psychological Tests; Psychopathology | 1986 |
Urinary 3-methoxy, 4-hydroxyphenylethylene glycol and therapeutic response to maprotiline and indalpine in major depression.
Topics: Adult; Age Factors; Anthracenes; Depression; Female; Glycols; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Opium; Piperidines; Sex Factors | 1986 |
Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline.
Topics: Anthracenes; Depressive Disorder; Female; Glycols; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Norepinephrine; Receptors, Adrenergic; Time Factors | 1981 |
Noradrenergic and serotoninergic depression?
Topics: Adult; Aged; Brain; Clomipramine; Depressive Disorder; Dexamethasone; Humans; Hydrocortisone; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Receptors, Adrenergic; Receptors, Serotonin; Serotonin | 1993 |
Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Depressive Disorder; Female; Fluoxetine; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Personality Inventory; Prognosis; Serotonin; Treatment Outcome | 1997 |
10 other study(ies) available for maprotiline and methoxyhydroxyphenylglycol
| Article | Year |
|---|---|
Pharmacological specificity is not the same as clinical selectivity.
Topics: Depressive Disorder; Double-Blind Method; Humans; Hydroxyindoleacetic Acid; Maprotiline; Methoxyhydroxyphenylglycol; Zimeldine | 1987 |
[Study of the metabolism of cerebral noradrenaline in depressed patients by the assay of plasma dihydroxyphenylethylene glycol].
Topics: Adult; Antidepressive Agents; Brain; Depressive Disorder; Dexamethasone; Female; Glycols; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Piperidines | 1985 |
Plasma 3,4-dihydroxyphenylethyleneglycol and therapeutic response to maprotiline and indalpine in major depression.
Topics: Adult; Aged; Anthracenes; Depression; Female; Glycols; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Piperidines | 1986 |
Studies on 3-methoxy-4-hydroxyphenylglycol (MHPG) and 3,4-dihydroxyphenylglycol (DHPG) levels in human urine, plasma and cerebrospinal fluids, and their significance in studies of depression.
Topics: Adult; Chromatography, High Pressure Liquid; Depression; Glycols; Humans; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine | 1986 |
Hypothesis of a deficiency of central noradrenergic input in DST nonsuppressor depressed patients. A clinical study with determination of DST and plasma DOPEG: negative results.
Topics: Brain; Depressive Disorder; Dexamethasone; Glycols; Humans; Hypothalamo-Hypophyseal System; Maprotiline; Methoxyhydroxyphenylglycol; Norepinephrine; Piperidines; Pituitary-Adrenal System; Random Allocation | 1985 |
Urinary amine metabolites in depression: a combined biochemical and general practice study: II. Biochemical aspects.
Topics: Adolescent; Adult; Aged; Biogenic Amines; Clomipramine; Depression; Family Practice; Female; Humans; Hydroxyindoleacetic Acid; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Time Factors | 1980 |
[Biochemical, pharmacologic and psychophysiologic studies for the optimization of drug therapy in depressive illnesses].
Topics: Amitriptyline; Antidepressive Agents; Arousal; Depressive Disorder; Double-Blind Method; Electroencephalography; Evoked Potentials; Glycols; Humans; Maprotiline; Methoxyhydroxyphenylglycol | 1984 |
Response to maprotiline treatment in depressive patients relationship to urinary MHPG excretion and plasma drug level.
Topics: Adult; Aged; Anthracenes; Depressive Disorder; Female; Glycols; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Time Factors | 1982 |
Possible pathophysiological mechanisms in subtypes of unipolar depressive disorders based on differences in urinary MHPG levels [proceedings].
Topics: Depressive Disorder; Glycols; Humans; Hydrocortisone; Imipramine; Maprotiline; Methoxyhydroxyphenylglycol; Norepinephrine; Statistics as Topic | 1981 |
MHPG as a predictor of antidepressant response to imipramine and maprotiline.
Topics: Adult; Anthracenes; Depressive Disorder; Female; Glycols; Humans; Imipramine; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged | 1980 |